ELOCP34

Across TCGA pan-cancer cohorts, ELOCP34 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated ELOCP34 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ELOCP34 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ELOCP34 expression acts as an unfavorable survival marker.

UCEC and LAML are the cancer types where ELOCP34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.108	0.839	<.001	90	view →
LAML	DFS	Tertile	All	0.221	0.587	.039	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ELOCP34–UCEC (DFS)

Open the UCEC breakdown →